Processa Necrobiosis Lipoidica Study

  • 18-80 years old
  • Biopsy confirmed diagnosis (within 5 years) or will be conducted at screening visit
  • Must have at least 1 ulcer with a minimum ulcer surface area of 1cm2  and total ulcer area of a minimum of 2 cm2
  • No more than 6 ulcers
  • 6 week washout for the following medications: oral corticosteroids, topical drugs, systemic pentoxifylline/theophylline/cilostazol, oral retinoids, and other systemic immunosuppressant or immunomodulatory drugs
  • No biologics within 12 weeks of baseline
  • No phototherapy or skin grafting within 6 weeks of baseline

*6 months of treatment

*Titrated dosing starting at 300 mg twice a day up to 600 mg twice a day

*50/50 chance to get drug or placebo

Other Information 

  • Compensation for time & travel available for most studies.

If you are interested in participating in one of these studies, please provide your contact information below. If you are a qualified candidate, a representative from our research department will be in touch with you.

Volunteer for this study!

  • This field is for validation purposes and should be left unchanged.